Searched over 200M research papers
10 papers analyzed
These studies suggest that chronic daily headache (CDH) affects 4-5% of the global population, is a complex condition with multiple causes, and significantly impacts quality of life and productivity, with no approved therapies and challenging management.
20 papers analyzed
Chronic Daily Headache (CDH) is a term used to describe a group of headache disorders characterized by the presence of headache on at least 15 days per month for a minimum of three months . CDH encompasses several subtypes, including chronic (transformed) migraine, chronic tension-type headache, new daily persistent headache, and hemicrania continua . These subtypes can be further classified based on the duration of individual headache episodes: short-duration headaches (less than 4 hours per attack) and long-duration headaches (greater than or equal to 4 hours per attack) .
CDH affects approximately 4-5% of the general population worldwide, making it a significant public health issue . This prevalence is consistent across various age groups, including the elderly. The high prevalence underscores the need for effective management strategies and increased awareness among healthcare providers.
The pathophysiology of CDH is complex and multifactorial. It often involves the transformation of episodic headache forms into chronic conditions, sometimes exacerbated by medication overuse . Psychiatric comorbidities, such as anxiety and depression, are also commonly associated with CDH, complicating its management and treatment outcomes.
The diagnosis of CDH requires the exclusion of secondary causes through appropriate investigations, often necessitating imaging studies like MRI, which is superior to CT in identifying underlying issues . The lack of specific diagnostic criteria for CDH in the International Headache Society (IHS) classification has historically led to challenges in consistent diagnosis and treatment.
CDH significantly impairs quality of life (QoL) and is associated with greater disability and productivity loss compared to episodic headaches. Patients with CDH, particularly those with medication overuse headache (MOH), experience more frequent healthcare consultations, longer hospitalizations, and higher direct medical costs. This highlights the substantial economic burden of CDH on both individuals and healthcare systems.
Currently, no specific therapies have been approved for CDH, and there have been few large-scale controlled trials of treatments. Management strategies often include both pharmacological and non-pharmacological approaches. Successful treatment plans can be life-changing for patients, but many individuals with CDH lapse from medical care and seek alternative therapies due to the chronic nature of their condition and the challenges in managing it effectively .
Chronic daily headache is a prevalent and debilitating condition that poses significant challenges in diagnosis and management. Despite its high prevalence and impact on quality of life, there remains a need for more effective treatment strategies and increased awareness among healthcare providers. Addressing the complexities of CDH requires a multifaceted approach, including better diagnostic criteria, comprehensive management plans, and ongoing research to develop targeted therapies.
Most relevant research papers on this topic